SEC Form 4 · accession 0001642247-17-000020
Perspective Therapeutics, Inc. · CATX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip J Vitale
Director
Period of report
Nov 16, 2017
Accepted (ET)
Nov 17, 2017 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000728387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 16, 2017 | P | 100 | $0.425 | A | 40,100 | D | |
| Common Stock | Nov 16, 2017 | P | 100 | $0.4251 | A | 40,200 | D | |
| Common Stock | Nov 16, 2017 | P | 8,480 | $0.43 | A | 48,680 | D | |
| Common Stock | Nov 16, 2017 | P | 200 | $0.4304 | A | 48,880 | D | |
| Common Stock | Nov 16, 2017 | P | 400 | $0.4389 | A | 49,280 | D | |
| Common Stock | Nov 16, 2017 | P | 3,049 | $0.438 | A | 52,329 | D | |
| Common Stock | Nov 16, 2017 | P | 18 | $0.435 | A | 52,347 | D | |
| Common Stock | Nov 16, 2017 | P | 1,400 | $0.439 | A | 53,747 | D | |
| Common Stock | Nov 16, 2017 | P | 1,606 | $0.44 | A | 55,353 | D | |
| Common Stock | Nov 16, 2017 | P | 496 | $0.4399 | A | 55,849 | D | |
| Common Stock | Nov 16, 2017 | P | 300 | $0.4362 | A | 56,149 | D | |
| Common Stock | Nov 16, 2017 | P | 300 | $0.4425 | A | 56,449 | D | |
| Common Stock | Nov 16, 2017 | P | 12,851 | $0.45 | A | 69,300 | D | |
| Common Stock | Nov 16, 2017 | P | 600 | $0.449 | A | 69,900 | D | |
| Common Stock | Nov 16, 2017 | P | 100 | $0.444 | A | 70,000 | D |
Table II — derivative securities
No Table II lines on this filing.